ClinicalTrials.gg
CompletedNCT01634451DESISTUpdated Jun 11, 2015

Development and Evaluation of Strategies to Improve Sedation Quality in InTensive Care

An interventional study of Bespoke on-line sedation education package and Sedation specific outcome process feedback in Critical Illness, sponsored by University of Edinburgh. Completed at 1 site in United Kingdom. Open to participants aged 16 Years and older. Per ClinicalTrials.gov, last updated 2015-06-11.

Sponsored by University of Edinburgh · Not applicable and Interventional

Phase
Not applicable
Study type
Interventional
Enrollment
1,637
Allocation
Randomized
Ages
16 Years and older
Sex
All
01

Study summary

Intensive Care Units (ICUs) across Scotland are working with the Scottish Patient Safety Programme (SPSP) to reduce healthcare associated infections (HAls). This is being done through implementation of "care bundles". Ensuring that ICU patients get the correct amount of sedation (medicine that makes patients sleepy) is part of this bundle, but is proving the most difficult to get right. It's important healthcare staff (nurses and doctors) get sedation levels correct because too much sedation is linked with increased hospital acquired infections (HAIs), longer intensive care (ICU) and hospital stays, and possibly higher death rates. This quality improvement project will develop and introduce three interventions that may improve sedation practice: first, an ICU sedation education package; second, feedback of sedation-related performance data (graphs and charts); and third, introduction of a CE (Conformité Européenne - With the CE marking on a product, the manufacturer ensures that the product conforms with the essential requirements of European regulations) marked new technology designed to improve sedation management. The investigators will study the effect these interventions, in different combinations, have on sedation management and quality in the participating ICUs. Eight ICUs in Scotland will take part in the project, pairs (2 ICUs) will be assigned randomly to different combinations as follows: 1.Enhanced education alone, 2. Education plus process/outcome measure feedback (graphs and charts), 3. Education plus introduction of a new sedation monitoring technology, or 4. Education,process/outcome measure feedback, and sedation monitoring technology. The investigators will evaluate which combinations of education, feedback, and technology provide the most patient benefit in the NHS. In addition both nursing \& medical staff will be observed in clinical practice \& interviewed about their clinical practice to increase understanding about sedation management from different view points and inform the education package content. These data will also help implement the findings after the research is completed if a benefit is found.

02

Conditions studied

  • Critical Illness

Browse trials for

Keywords

  • Sedation
  • Quality
03

In context

Critical Illness

1,923 studies on the registry are indexed under Critical Illness; 465 are open to participants now.

This study's enrollment of 1,637 is above the median of 90 across 1,003 interventional studies indexed under Critical Illness.

Browse Critical Illness studies →

Lead sponsor

University of Edinburgh is the lead sponsor of 403 studies on the registry; 65 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. All patients admitted to ICU mechanically ventilated and intubated.
  2. All patients in whom mechanical ventilation via an endotracheal tube is instituted at some time after ICU admission will also be eligible for inclusion from the time intubation and mechanical ventilation begins.

Exclusion criteria

Exclusion Criteria:

  1. Patients who are not receiving mechanical ventilation via an endotracheal tube
  2. Patients who received mechanical ventilation following ICU admission but this has been discontinued at the time of screening for study inclusion
  3. Patients in whom discontinuation of mechanical ventilation is anticipated in the next 4 hours
  4. Patients in whom a decision to withdraw active therapy has been made
  5. Patients who have already been enrolled in the during the same hospital admission
  6. Patients whom have been mechanically ventilated and intubated for greater than 24 hrs by the time relatives are approached for consent
05

Study design

Phase
Not applicable
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
1,637 participants (actual)

Study arms

  • Active comparator
    Education Package

    2 ICUs; one large and one small. Randomised to receive bespoke education package for the 9 month intervention period

    Other: Bespoke on-line sedation education package

  • Active comparator
    Education and Feedback

    2 ICUs; one large and one small. Randomised to receive a bespoke education package and real-time,site specific, outcome process feedback they will disseminate to their staff for the 9 month intervention period.

    Other: Sedation specific outcome process feedback

  • Active comparator
    Education and Sedation Monitoring

    2 ICUs; one large and one small. Randomised to receive a bespoke education package and a new novel sedation (responsiveness) monitor for the 9 month intervention period.

    Device: Responsiveness monitoring; novel sedation monitor

  • Active comparator
    Education, Feedback, Sedation Monitoring

    2 ICUs; one large and one small. Randomised to receive a bespoke education package, real-time,site specific, outcome process feedback they will disseminate to their staff and a new novel sedation (responsiveness) monitor for the 9 month intervention period.

    Other: Sedation specific outcome process feedback · Device: Responsiveness monitoring; novel sedation monitor

Interventions

  • OtherBespoke on-line sedation education package

    A bespoke on-line education package has been developed and will be accessible by all ICU nursing staff. They will have unique logins and the system will track their use and completion of the education package. There is a small multiple choice assessment at the end of the package.

    Also known as: Bespoke Education Package

  • OtherSedation specific outcome process feedback

    Using statistical process charts, the data gathered from the Sedation quality Tools (SQATs) completed each shift by the ICU nurses, will be fed back highlighting sedation specific outcomes e.g. number of over sedated days per 1000 ventilator days.

    Also known as: Sedation pecific outcome process feedback

  • DeviceResponsiveness monitoring; novel sedation monitor

    Responsiveness monitoring (developed by GE Healthcare) is a novel technology used to monitor patient responsiveness and essentially alert ICU nursing staff when their patients may be over sedated.

    Also known as: Responsiveness Monitoring

06

What researchers measure

Primary outcomes

  1. Change from baseline the effect of individual and combinations of the interventions named on achievement of optimal sedation practice

    The % of ventilated patient days with optimal sedation will be compared across and between the groups. A sedation quality assessment tool has been developed for the purpose of the study: Group 1 -Education package only (bespoke sedation education) Group 2 -Education package and real time (site specific) process feedback about sedation practices Group 3 - Education and responsiveness (sedation) technology Group 4 - Education package, real time (site specific) process feedback about sedation practices and responsiveness (sedation) technology

    Time frame: Cluster trial examining group effects over a 20 month period. Data available June 2014.

Secondary outcomes

  1. Number of ventilation days

    Time frame: Cluster trial examining group effects over a 20 month period. Data available June 2014.

  2. ICU stay duration

    Time frame: Cluster trial examining group effects over a 20 month period. Data available June 2014.

  3. Number of days on sedation

    Time frame: Cluster trial examining group effects over a 20 month period. Data available June 2014.

07

Study locations

1 site
  • Royal Infirmary Edinburgh, Glasgow Royal Infirmary, Monklands Hospital, Victoria Infirmary Glasgow, Forth Valley Royal, Ninewells hospital, Dumfries Infirmary , Victoria Hospital Kirkcaldy
    Edinburgh, Glasgow, Airdrie, Larbert, Dumfries, Dundee, United Kingdom
08

References and documents

Publications

  • Kydonaki K, Hanley J, Huby G, Antonelli J, Walsh TS; Development and Evaluation of Strategies to Improve Sedation practice in inTensive care (DESIST) study investigators. Challenges and barriers to optimising sedation in intensive care: a qualitative study in eight Scottish intensive care units. BMJ Open. 2019 May 24;9(5):e024549. doi: 10.1136/bmjopen-2018-024549. PubMed 31129576 ↗
  • Walsh TS, Kydonaki K, Antonelli J, Stephen J, Lee RJ, Everingham K, Hanley J, Phillips EC, Uutela K, Peltola P, Cole S, Quasim T, Ruddy J, McDougall M, Davidson A, Rutherford J, Richards J, Weir CJ; Development and Evaluation of Strategies to Improve Sedation Practice in Intensive Care (DESIST) study investigators. Staff education, regular sedation and analgesia quality feedback, and a sedation monitoring technology for improving sedation and analgesia quality for critically ill, mechanically ventilated patients: a cluster randomised trial. Lancet Respir Med. 2016 Oct;4(10):807-817. doi: 10.1016/S2213-2600(16)30178-3. Epub 2016 Jul 26. PubMed 27473760 ↗
  • Walsh TS, Kydonaki K, Antonelli J, Stephen J, Lee RJ, Everingham K, Hanley J, Uutelo K, Peltola P, Weir CJ; Development and Evaluation of Strategies to Improve Sedation practice in in Tensive care Study Investigators. Rationale, design and methodology of a trial evaluating three strategies designed to improve sedation quality in intensive care units (DESIST study). BMJ Open. 2016 Mar 4;6(3):e010148. doi: 10.1136/bmjopen-2015-010148. PubMed 26944693 ↗
09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Jun 2012, a primary completion of Dec 2014 and a completion of Dec 2014. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 20, 2012
First posted
Jul 6, 2012
Start
Jun 2012
Primary completionActual
Dec 2014
CompletionActual
Dec 2014
Last update
Jun 11, 2015
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 11, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01634451
Collaborators
Chief Scientist Office of the Scottish Government, GE Healthcare
Responsible party
Sponsor
First posted
Jul 6, 2012
Start date
Jun 2012
Primary completion
Dec 2014
Completion
Dec 2014
Last update
Jun 11, 2015

Study contacts

Timothy S Walsh, MD
principal investigator · University of Edinburgh

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion